Limula Biotech Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5.71M
- Investors
-
18
Limula Biotech General Information
Description
Developer of automated cell therapy manufacturing platforms designed for scalable production. The company's platform integrates bioreactor and centrifuge functionalities into a single device, automating complex cell processing steps without human intervention, featuring in-situ centrifugation, modular design, scalability, versatility for various cell types, and an intuitive user interface, enabling biotech and pharmaceutical companies to transition from open, manual methods to closed, automated processes, improving efficiency and accessibility in cell and gene therapy manufacturing.
Contact Information
Website
www.limula.chCorporate Office
- Rte de la Corniche 5
- 1066 Epalinges
- Switzerland
Corporate Office
- Rte de la Corniche 5
- 1066 Epalinges
- Switzerland
Limula Biotech Timeline
Limula Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 21. Seed Round | 21-May-2024 | $5.71M | Completed | Generating Revenue | ||
| 20. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 19. Grant | 16-Oct-2023 | Completed | Generating Revenue | |||
| 18. Accelerator/Incubator | 01-Jun-2023 | Completed | Startup | |||
| 17. Grant | 30-May-2023 | Completed | Startup | |||
| 16. Grant | 01-Dec-2022 | Completed | Startup | |||
| 15. Grant | 02-May-2022 | Completed | Startup | |||
| 14. Seed Round | 16-Feb-2022 | Completed | Startup | |||
| 13. Accelerator/Incubator | 16-Feb-2022 | $5.91M | Completed | Startup | ||
| 12. Grant | 24-Jan-2022 | $16.4K | $5.91M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Limula Biotech Comparisons
Industry
Financing
Details
Limula Biotech Competitors (8)
One of Limula Biotech’s 8 competitors is Cellares, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellares | Venture Capital-Backed | South San Francisco, CA | ||||
| Ori Biotech | Venture Capital-Backed | London, United Kingdom | ||||
| Astraveus | Venture Capital-Backed | Paris, France | ||||
| MFX | Venture Capital-Backed | Stevenage, United Kingdom | ||||
| Adva Biotechnology | Venture Capital-Backed | Ahihud, Israel |
Limula Biotech Patents
Limula Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023478822-A1 | Bioprocess chamber with frustum-shaped section | Pending | 28-Dec-2023 | ||
| EP-4833293-A1 | Bioprocess chamber with frustum-shaped section | Pending | 28-Dec-2023 | ||
| WO-2025140774-A1 | Bioprocess chamber with frustum-shaped section | Inactive | 28-Dec-2023 | ||
| CA-227726-S | Bioreactor vessel | Active | 28-Dec-2023 | ||
| CA-227727-S | Bioreactor vessel | Active | 28-Dec-2023 |
Limula Biotech Signals
Limula Biotech Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lichtsteiner Foundation | Limited Partner | Minority | ||
| Life Extension Ventures | Venture Capital | Minority | ||
| Oxford Saïd Business School | University | Minority | ||
| Verve Ventures | Venture Capital | Minority | ||
| W. A. de Vigier Foundation | Limited Partner | Minority |
Limula Biotech FAQs
-
When was Limula Biotech founded?
Limula Biotech was founded in 2020.
-
Where is Limula Biotech headquartered?
Limula Biotech is headquartered in Epalinges, Switzerland.
-
What is the size of Limula Biotech?
Limula Biotech has 20 total employees.
-
What industry is Limula Biotech in?
Limula Biotech’s primary industry is Biotechnology.
-
Is Limula Biotech a private or public company?
Limula Biotech is a Private company.
-
What is the current valuation of Limula Biotech?
The current valuation of Limula Biotech is .
-
What is Limula Biotech’s current revenue?
The current revenue for Limula Biotech is .
-
How much funding has Limula Biotech raised over time?
Limula Biotech has raised $12M.
-
Who are Limula Biotech’s investors?
Lichtsteiner Foundation, Life Extension Ventures, Oxford Saïd Business School, Verve Ventures, and W. A. de Vigier Foundation are 5 of 18 investors who have invested in Limula Biotech.
-
Who are Limula Biotech’s competitors?
Cellares, Ori Biotech, Astraveus, MFX, and Adva Biotechnology are some of the 8 competitors of Limula Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process